市場調查報告書
商品編碼
964997

皮膚消毒劑產品市場增長,趨勢和預測(2020-2025)

Skin Antiseptic Products Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

出版日期: | 出版商: Mordor Intelligence Pvt Ltd | 英文 110 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

皮膚消毒產品的市場規模預計在預測期內以7.5%的複合年增長率增長。醫院內感染(HAI)的患病率增加,缺乏衛生設施和預防措施以及手術室和內窺鏡再治療的增加使用,對這些產品的需求不斷增加。此外,由於更高的醫療費用,更高的醫院內感染髮生率以及人們對清潔和消毒措施的意識增強,預計全球行業將以更高的速度增長。皮膚消毒劑用於維持人類或非生物有機體的完整性。根據世界衛生組織的數據,不斷估計發達國家中多達7%的患者和新興國家中有10%的患者至少患有一種院內感染。這些傳染病也給社會帶來了沉重的經濟負擔。但是,通過有效的感染控制和管理,可以預防大多數醫院內感染。

該報告調查了皮膚消毒劑產品市場,並提供了市場概況以及按配方,類型,應用,區域和進入市場的公司概況的趨勢。

目錄

第1章簡介

第2章調查方法

第3章執行摘要

第4章市場動態

  • 市場概況
  • 市場驅動力
    • 院內感染發生率增加
    • 操作次數增加
  • 市場限制音速
    • 副作用和通透性風險
  • 波特的五力分析

第5章市場細分

  • 根據處方
    • 酒精
    • 氯己定
    • 其他
  • 按類型
    • 解決方案
    • 棉棒
    • 抹布
  • 按應用
    • 手術
    • 注射
    • 其他
  • 按地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東/非洲
    • 南美洲

第6章競爭情況

  • 公司簡介
    • Becton Dickinson and Company
    • 3M Company
    • Ecolab Inc.
    • Schelke & Mayr GmbH
    • Sage Products LLC
    • Johnson & Johnson
    • B. Braun Melsungen AG

第7章市場機會和未來趨勢

目錄
Product Code: 68898

The skin antiseptic products market is projected to register a CAGR of 7.5% over the forecast period. The demand for these products is increasing, due to a higher prevalence of Hospital Acquired Infections (HAIs), lack of sanitation and precaution, and increased use of surgical units and endoscope reprocesses. Furthermore, the global industry is witnessing a higher rate of growth, due to increased expenditure on healthcare, elevated incidences of hospital-acquired infectious diseases, and increased awareness of cleanliness and disinfection measures. Skin antiseptic is used to maintain human or non-living germ-free. According to the World Health Organization, at any time, up to 7% of patients in developed and 10% in developing countries will acquire at least one HAI. These infections also present a significant economic burden at the societal level. However, a large percentage of HAIs are preventable through effective infection prevention and control measures.

Key Market Trends

Alcohols Segment is Dominating the Skin Antiseptic Products Market

The alcohols segment led the market, owing to an increased usage of formulation for pre-injection and pre-operative skin preparation. Furthermore, the increasing demand for alcohol base to be used in combination with other formulations, such as iodine and chlorhexidine, is fueling the segment growth. Furthermore, it comprises antiseptic agents, such as isopropyl or ethyl, which are effective against different microbes. The sales of antiseptics that are alcohol-based increased significantly, due to the outbreak of COVID-19.

The increasing prevalence of hospital-acquired infections and the increasing number of surgeries are boosting the growth of the segment.

North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to dominate the overall market, throughout the forecast period. The market growth is due to the factors such as the presence of key players, high prevalence of nosocomial infections in the region, established healthcare infrastructure. In this region the United States has the maximum share due to supportive healthcare policies, high number of patients, and a developed healthcare market. The US Center for Disease Control and Prevention identifies that nearly 1.7 million hospitalized patients annually acquire nosocomial infections while being treated for other health issues and that more than 98,000 patients die due to these.

Competitive Landscape

The skin antiseptic products market is moderately competitive and consists of several major players. Some of the companies currently dominating the market are BD, 3M, Ecolab, Schulke & Mayr GmbH, Sage Products LLC, Johnson & Johnson, and B. Braun Melsungen AG.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Prevalence of Hospital-acquired Infections
    • 4.2.2 Increasing Number of Surgeries
  • 4.3 Market Restraints
    • 4.3.1 Side effects and risk of Permeability
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Formulation
    • 5.1.1 Alcohols
    • 5.1.2 Chlorhexidine
    • 5.1.3 Iodine
    • 5.1.4 Other Formulations
  • 5.2 By Type
    • 5.2.1 Solutions
    • 5.2.2 Swab Sticks
    • 5.2.3 Wipes
  • 5.3 By Application
    • 5.3.1 Surgeries
    • 5.3.2 Injection
    • 5.3.3 Other Applications
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Becton Dickinson and Company
    • 6.1.2 3M Company
    • 6.1.3 Ecolab Inc.
    • 6.1.4 Schelke & Mayr GmbH
    • 6.1.5 Sage Products LLC
    • 6.1.6 Johnson & Johnson
    • 6.1.7 B. Braun Melsungen AG

7 MARKET OPPORTUNITIES AND FUTURE TRENDS